Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
FDA’s Class II Classification: Blood Collection Device for Cell-Free Nucleic Acids
$9.99
Discover the FDA’s strategic approach to classifying blood collection devices for cell-free nucleic acids into Class II. This course dissects the implications of this classification, focusing on the required special controls that ensure device safety, effectiveness, and regulatory compliance. Enhance your understanding of how these measures facilitate patient access to innovative technologies by mitigating risks and reducing regulatory hurdles.
In this course you will learn the following:
* Understand the classification process and criteria for medical devices.
* Identify the special controls applicable to the blood collection device for cell-free nucleic acids.
* Recognize the regulatory pathways and requirements for compliance.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
| Federal Register Title | Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Blood Collection Device for Cell-Free Nucleic Acids. Document Number: 2024-20254 |
|---|---|
| Course SKU | FR-24-231-1 |
| Why This Course Is Important | Without this course, you may lack crucial insights into the FDA's classification process and the specific special controls essential for compliance and safe device operation. |